The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) was established in October 2001 to conduct large multi-institutional clinical trials.  The trials will address important issues in hematopoietic stem cell transplantation (HSCT), thereby furthering understanding of the best possible treatment approaches.  Participating BMT CTN investigators collaborate through an organization designed to maintain continuity of operations, to facilitate effective communication and cooperation among participating transplant centers and with collaborators at the National Institutes of Health, and to offer trials participation to patients in all regions of the U.S.

BMT CTN Network Request for BMT CTN 1202 Correlative Laboratory Study Proposals

Announcing the release of a request for laboratory study proposals utilizing biospecimens from the national BMT CTN 1202 resource. In this initial BMT CTN Network release, the BMT CTN is calling for meritorious laboratory study proposals from investigators who wish to perform exploratory and/or biomarker validation studies. Please promptly review the attached Request for Proposal and Proposal Submission Template documents, and feel free to send any questions that you may have directly to Alan Howard (ahoward@nmdp.org). Study proposals deadline has been extended through June 10, 2020.

BMT CTN 1202 Request for Laboratory Study Proposals
BMT CTN 1202 Ancillary Study Proposal Template